Toxic effects of flufenoxuron on development and vascular formation during zebrafish embryogenesis

Sunwoo Park, Jin Young Lee, Hahyun Park, Gwonhwa Song, Whasun Lim

Research output: Contribution to journalArticle

Abstract

Flufenoxuron, a chitin synthesis inhibitor that is widely used in developed countries as an insecticide, is rarely degraded in the environment. In addition to that in insects, flufenoxuron-mediated non-targeted death in organisms such as lizards and bees has been reported. However, the toxic effects of this compound on vascular development during embryogenesis, as well as the underlying mechanism, have not yet been elucidated. In the present study, we assessed abnormal development and cardiovascular damage induced by flufenoxuron in zebrafish embryos. Exposed zebrafish had malformed eyes and pathological characteristics such as heart and yolk sac edema. In accordance with developmental inhibition, cell cycle regulatory genes were dysregulated in zebrafish embryos upon exposure to flufenoxuron. We also discovered that this agent can disrupt vascular formation by interfering with angiogenesis-associated genes including the genes encoding vascular endothelial growth factor Aa (vegfaa), vegfc, fms-related tyrosine kinase 1 (flt1), and flt4 in zebrafish embryos. These anti-angiogenic effects of flufenoxuron were further verified using a well-known angiogenesis model, namely human umbilical vein endothelial cells. In conclusion, our results suggest that flufenoxuron inhibits overall development and angiogenesis during embryogenesis.

Original languageEnglish
Article number105307
JournalAquatic Toxicology
Volume216
DOIs
Publication statusPublished - 2019 Nov 1

Fingerprint

flufenoxuron
Poisons
Zebrafish
Danio rerio
blood vessels
Embryonic Development
Blood Vessels
embryo
embryogenesis
gene
angiogenesis
embryo (animal)
Embryonic Structures
chitin
lizard
bee
insecticide
inhibitor
chitin synthesis inhibitors
insect

Keywords

  • Angiogenesis
  • Development
  • Embryotoxicity
  • Flufenoxuron
  • Zebrafish

ASJC Scopus subject areas

  • Aquatic Science
  • Health, Toxicology and Mutagenesis

Cite this

Toxic effects of flufenoxuron on development and vascular formation during zebrafish embryogenesis. / Park, Sunwoo; Lee, Jin Young; Park, Hahyun; Song, Gwonhwa; Lim, Whasun.

In: Aquatic Toxicology, Vol. 216, 105307, 01.11.2019.

Research output: Contribution to journalArticle

@article{297e4db50b894c7599b77c4257801cca,
title = "Toxic effects of flufenoxuron on development and vascular formation during zebrafish embryogenesis",
abstract = "Flufenoxuron, a chitin synthesis inhibitor that is widely used in developed countries as an insecticide, is rarely degraded in the environment. In addition to that in insects, flufenoxuron-mediated non-targeted death in organisms such as lizards and bees has been reported. However, the toxic effects of this compound on vascular development during embryogenesis, as well as the underlying mechanism, have not yet been elucidated. In the present study, we assessed abnormal development and cardiovascular damage induced by flufenoxuron in zebrafish embryos. Exposed zebrafish had malformed eyes and pathological characteristics such as heart and yolk sac edema. In accordance with developmental inhibition, cell cycle regulatory genes were dysregulated in zebrafish embryos upon exposure to flufenoxuron. We also discovered that this agent can disrupt vascular formation by interfering with angiogenesis-associated genes including the genes encoding vascular endothelial growth factor Aa (vegfaa), vegfc, fms-related tyrosine kinase 1 (flt1), and flt4 in zebrafish embryos. These anti-angiogenic effects of flufenoxuron were further verified using a well-known angiogenesis model, namely human umbilical vein endothelial cells. In conclusion, our results suggest that flufenoxuron inhibits overall development and angiogenesis during embryogenesis.",
keywords = "Angiogenesis, Development, Embryotoxicity, Flufenoxuron, Zebrafish",
author = "Sunwoo Park and Lee, {Jin Young} and Hahyun Park and Gwonhwa Song and Whasun Lim",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.aquatox.2019.105307",
language = "English",
volume = "216",
journal = "Aquatic Toxicology",
issn = "0166-445X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Toxic effects of flufenoxuron on development and vascular formation during zebrafish embryogenesis

AU - Park, Sunwoo

AU - Lee, Jin Young

AU - Park, Hahyun

AU - Song, Gwonhwa

AU - Lim, Whasun

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Flufenoxuron, a chitin synthesis inhibitor that is widely used in developed countries as an insecticide, is rarely degraded in the environment. In addition to that in insects, flufenoxuron-mediated non-targeted death in organisms such as lizards and bees has been reported. However, the toxic effects of this compound on vascular development during embryogenesis, as well as the underlying mechanism, have not yet been elucidated. In the present study, we assessed abnormal development and cardiovascular damage induced by flufenoxuron in zebrafish embryos. Exposed zebrafish had malformed eyes and pathological characteristics such as heart and yolk sac edema. In accordance with developmental inhibition, cell cycle regulatory genes were dysregulated in zebrafish embryos upon exposure to flufenoxuron. We also discovered that this agent can disrupt vascular formation by interfering with angiogenesis-associated genes including the genes encoding vascular endothelial growth factor Aa (vegfaa), vegfc, fms-related tyrosine kinase 1 (flt1), and flt4 in zebrafish embryos. These anti-angiogenic effects of flufenoxuron were further verified using a well-known angiogenesis model, namely human umbilical vein endothelial cells. In conclusion, our results suggest that flufenoxuron inhibits overall development and angiogenesis during embryogenesis.

AB - Flufenoxuron, a chitin synthesis inhibitor that is widely used in developed countries as an insecticide, is rarely degraded in the environment. In addition to that in insects, flufenoxuron-mediated non-targeted death in organisms such as lizards and bees has been reported. However, the toxic effects of this compound on vascular development during embryogenesis, as well as the underlying mechanism, have not yet been elucidated. In the present study, we assessed abnormal development and cardiovascular damage induced by flufenoxuron in zebrafish embryos. Exposed zebrafish had malformed eyes and pathological characteristics such as heart and yolk sac edema. In accordance with developmental inhibition, cell cycle regulatory genes were dysregulated in zebrafish embryos upon exposure to flufenoxuron. We also discovered that this agent can disrupt vascular formation by interfering with angiogenesis-associated genes including the genes encoding vascular endothelial growth factor Aa (vegfaa), vegfc, fms-related tyrosine kinase 1 (flt1), and flt4 in zebrafish embryos. These anti-angiogenic effects of flufenoxuron were further verified using a well-known angiogenesis model, namely human umbilical vein endothelial cells. In conclusion, our results suggest that flufenoxuron inhibits overall development and angiogenesis during embryogenesis.

KW - Angiogenesis

KW - Development

KW - Embryotoxicity

KW - Flufenoxuron

KW - Zebrafish

UR - http://www.scopus.com/inward/record.url?scp=85072376190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072376190&partnerID=8YFLogxK

U2 - 10.1016/j.aquatox.2019.105307

DO - 10.1016/j.aquatox.2019.105307

M3 - Article

AN - SCOPUS:85072376190

VL - 216

JO - Aquatic Toxicology

JF - Aquatic Toxicology

SN - 0166-445X

M1 - 105307

ER -